SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 2nd, 2017 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August [__, 2017, between Rosetta Genomics Ltd., an Israeli company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT WARRANT TO PURCHASE ORDINARY SHARES ROSETTA GENOMICS LTD.Warrant Agreement • August 2nd, 2017 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
THIS WARRANT TO PURCHASE ORDINARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM New York City time on ___, 2022 [THE FIFTH YEAR ANNIVERSARY OF THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT] (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., an Israeli company (the “Company”), up to ______ Ordinary Shares, NIS 7.2 par value (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Engagement Agreement, dated April 21, 2017, between the Company and Rodman & Renshaw, a unit of H.C. W
